SynthesisFrontiers in nutrition2025
Mediterranean diet research trajectories in China (2006-2025): a scoping review and scientometric analysis to localize global nutrition models.
Synthesis in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mediterranean-diet (MedDiet) principles are increasingly invoked to counter China's nutrition-transition-driven epidemic of cardiometabolic disease, yet no field-wide synthesis of this scholarship exists. A bibliometric assessment can expose thematic evolution, knowledge gaps and localization pathways. Methods: We systematically searched Web of Science Core Collection and CNKI for Chinese-affiliated MedDiet human-health articles published between 2006 and 2 February 2025. After PRISMA-ScR screening we retained 384 records. VOSviewer and COOC mapped co-authorship, citations and keywords; latent-Dirichlet allocation detected topic drift; compound annual growth rate (CAGR) and field-weighted citation impact (FWCI) indexed performance. All data and scripts are openly archived. Results: Annual output climbed from one article in 2006 to 76 in 2022 (CAGR = 23%); FWCI = 1.34. Seven keyword clusters now pivot on gut-microbiome science, digital adherence and sustainability rather than early cardiometabolic replication. Temporal segmentation revealed three phases: replication (2006-2013), public-health expansion (2014-2019) and cross-disciplinary innovation (2020-2025). Bibliographic coupling resolved five citation schools; Jiangnan-diet localization has migrated into the leading clinical cluster. Lexical drift highlights ingredient substitution (rapeseed-oil phenolics) and late adoption of carbon-footprint terminology. Conclusion: Chinese MedDiet scholarship is recalibrating toward a culturally adapted, digitally enabled and climate-aligned paradigm. Longer m-health-supported trials, life-course epidemiology and multi-omics Jiangnan cohorts are warranted to translate current bibliometric momentum into population-level health and sustainability gains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.